What levels of prolactin are definitely suggestive of prolactinoma?'

Explanation

## Correct Answer: C. >200µg/L Prolactin levels >200 µg/L are **definitively diagnostic** of prolactinoma in clinical practice. While mild hyperprolactinemia (20–100 µg/L) can occur with medications (dopamine antagonists, metoclopramide, risperidone), hypothyroidism, chest wall irritation, or stress, levels exceeding 200 µg/L are virtually pathognomonic for a prolactin-secreting pituitary adenoma. This threshold is widely accepted in Indian endocrinology practice and international guidelines (Endocrine Society) because the pituitary lactotroph rarely produces prolactin at such high concentrations except in the setting of autonomous adenomatous secretion. Levels between 100–200 µg/L fall in an intermediate zone where other causes (particularly dopamine antagonists, severe hypothyroidism, or large non-functioning adenomas compressing the pituitary stalk) must be excluded before attributing the elevation to prolactinoma. The >200 µg/L cutoff provides the clinician with high specificity and confidence in diagnosis without requiring additional imaging or suppression testing in most cases. ## Why the other options are wrong **A. >150 µg/L** — This is wrong because 150 µg/L falls in the intermediate range where non-adenomatous causes (dopamine antagonists, severe hypothyroidism, stalk compression) remain plausible differential diagnoses. While suggestive of prolactinoma, it is not **definitive** without additional clinical correlation and imaging. The question specifically asks for levels that are 'definitely suggestive,' requiring higher specificity. **B. >100 µg/L** — This is wrong because 100 µg/L is too low a threshold and overlaps significantly with secondary causes of hyperprolactinemia. Medications like metoclopramide, risperidone, and severe hypothyroidism commonly cause prolactin levels in the 100–150 µg/L range in Indian patients. This threshold lacks the specificity needed for definitive diagnosis and would lead to unnecessary imaging and misdiagnosis. **D. >50 µg/L** — This is wrong because 50 µg/L is only mildly elevated and is commonly seen with physiological stress, medications, and non-adenomatous pituitary pathology. This threshold has very poor specificity and would result in overdiagnosis of prolactinoma. Most endocrinologists would not consider this level suggestive of adenoma without additional clinical and radiological evidence. ## High-Yield Facts - **Prolactin >200 µg/L** is virtually pathognomonic for prolactinoma; intermediate levels (100–200 µg/L) require exclusion of secondary causes. - **Dopamine antagonists** (metoclopramide, risperidone, haloperidol) cause hyperprolactinemia but rarely exceed 150 µg/L; >200 µg/L rules them out. - **Pituitary stalk compression** by non-functioning adenomas raises prolactin modestly (usually <100 µg/L) via loss of dopamine inhibition. - **Severe hypothyroidism** (TSH >50 mIU/L) can elevate prolactin to 100–150 µg/L; always check TSH before attributing hyperprolactinemia to prolactinoma. - **Prolactin >200 µg/L** correlates with larger adenomas (macroadenomas); microadenomas typically present with levels 100–200 µg/L. ## Mnemonics **PROLACTIN CUTOFFS (Indian Endocrinology Practice)** **<50**: Physiological/stress | **50–100**: Mild (drugs, hypothyroidism) | **100–200**: Intermediate (exclude secondaries, consider imaging) | **>200**: Prolactinoma (definitive) **SECONDARY CAUSES RULE** If prolactin >100 µg/L: Always check **TSH, medications, pregnancy, renal function** first. Only >200 µg/L bypasses this workup and points directly to adenoma. ## NBE Trap NBE may pair lower thresholds (100–150 µg/L) with "suggestive" language to trap students who confuse "suggestive" with "diagnostic." The question's use of "definitely suggestive" demands the highest specificity threshold (>200 µg/L), not merely elevated levels. ## Clinical Pearl In Indian practice, a young woman presenting with amenorrhea and galactorrhea with prolactin >200 µg/L requires MRI pituitary for adenoma confirmation and visual field assessment (risk of optic chiasm compression), but the diagnosis is already secure biochemically. Levels 100–200 µg/L demand a full medication and thyroid history before imaging, saving unnecessary healthcare costs. _Reference: Harrison Ch. 375 (Pituitary Disorders); Endocrine Society Clinical Practice Guidelines on Prolactinoma (2018)_